Delving into the Latest Updates on Zhongfu Pharmaceutical Co., Ltd. with Synapse

Overview

Tags

Cardiovascular Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Nervous System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	1

1主要研究目的以中孚药业股份有限公司生产的卡托普利片为受试制剂，以アルフレッサファーマ株式会社生产的卡托普利片(商品名：CAPTORIL®)为参比制剂，按生物等效性试验的相关规定，比较卡托普利片在中国健康受试者体内的药代动力学行为，评价两种制剂的生物等效性。 2次要研究目的评价中国健康受试者单次空腹口服卡托普利片受试制剂和参比制剂后的安全性。

[Translation]

1Main study objectives Captopril tablets produced by Zhongfu Pharmaceutical Co., Ltd. were used as the test preparation, and Captopril tablets (trade name: CAPTORIL®) produced by Alfred Pharmaceuticals Co., Ltd. were used as the reference preparation. According to the relevant provisions of the bioequivalence test, the pharmacokinetic behavior of Captopril tablets in healthy Chinese subjects was compared to evaluate the bioequivalence of the two preparations. 2Secondary study objectives Evaluate the safety of the test preparation and reference preparation of Captopril tablets after a single oral administration on an empty stomach in healthy Chinese subjects.

Start Date27 Aug 2021

Sponsor / Collaborator

Zhongfu Pharmaceutical Co., Ltd.

CTR20171364

/ TerminatedNot Applicable

卡托普利片在健康受试者中随机、开放、单剂量、双周期、双交叉空腹状态下的生物等效性试验

[Translation] A randomized, open-label, single-dose, two-period, double-crossover bioequivalence study of captopril tablets in healthy subjects under fasting conditions

以中孚药业股份有限公司提供的卡托普利片为受试制剂，按生物等效性试验的有关规定，与第一三共エスファ株式会社生产的卡托普利片（商品名：CAPTORIL®，参比制剂）对比在健康人体内的相对生物利用度，考察两制剂的人体生物等效性。

[Translation]

Captopril tablets provided by Zhongfu Pharmaceutical Co., Ltd. were used as the test preparation. According to the relevant provisions of the bioequivalence study, the relative bioavailability in healthy humans was compared with that of Captopril tablets produced by Daiichi Sankyo Esfa Co., Ltd. (trade name: CAPTORIL®, reference preparation) to investigate the bioequivalence of the two preparations in humans.

Start Date11 Dec 2017

Sponsor / Collaborator

Zhongfu Pharmaceutical Co., Ltd.

CTR20250059

/ Not yet recruitingPhase 3

评价盐酸西替利嗪注射液治疗急性荨麻疹的有效性和安全性随机、双盲、阳性药物平行对照的多中心III 期临床试验

[Translation] A randomized, double-blind, positive drug-controlled, multicenter phase III clinical trial to evaluate the efficacy and safety of cetirizine hydrochloride injection in the treatment of acute urticaria

以阳性药物为对照，评价盐酸西替利嗪注射液治疗急性荨麻疹的有效性和安全性

[Translation]

To evaluate the efficacy and safety of cetirizine hydrochloride injection in the treatment of acute urticaria using positive drugs as control

Start Date-

Sponsor / Collaborator

Zhongfu Pharmaceutical Co., Ltd.

100 Clinical Results associated with Zhongfu Pharmaceutical Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Zhongfu Pharmaceutical Co., Ltd.

Login to view more data

100 Deals associated with Zhongfu Pharmaceutical Co., Ltd.

Login to view more data

100 Translational Medicine associated with Zhongfu Pharmaceutical Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 14 Aug 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Login to view more data